Prediction of binding affinities for hydroxamic acid derivatives as urease inhibitors by molecular docking and 3D-QSAR studies

Letters in Drug Design and Discovery

Volumn 6, Issue 2, 2009, Pages 93-100

  Zaheer ul Haq, ^a   Wadood, Abdul ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

CoMFA; CoMSIA; Docking; Hydroxamic acid; Leave one out; Urease

Indexed keywords

HYDROXAMIC ACID DERIVATIVE; UREASE; UREASE INHIBITOR;

ARTICLE; BINDING AFFINITY; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG PROTEIN BINDING; MOLECULAR DOCKING; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 61949406976     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018009787582598     Document Type: Article

References (38)

1. Karplus, P.A.; Pearson, M.A.; Hausinger, R.P. 70 years of crystalline urease: what have we learned? Acc. Chem. Res., 1997, 30, 330-337.
2. Kolodziej, A.F. Progress in Inorganic Chemistry, Karlin, K.D, Ed.; John Wiley and sons: New York, 1994; Vol. 41, pp. 493-597.
3. Smoot, D.T.; Mobley. H.L.; Chippendale, G.R.; Lesison, J.F.; Resau, J.H. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect. Immun., 1990, 58, 1992-1994.
4. Bremner, J.M. Recent research on problems in the use of urea as a nitrogen fertilizer. Fert. Res., 1995, 42, 321-329.
5. Kobashi, K.; Hase, J.; Uehara, K. Specific inhibition of urease by hydroxamic acids. Biochim. Biophys. Acta, 1962, 65, 380-383.
6. Fishbein, W.N.; Carbone, P.P.; Hochstein, H.D. Acetohydroxamate: bacterial urease inhibitor with therapeutic potential in hyperammonaemic satates. Nature, (Lond.) 1965, 208, 46-48.
7. Gale, G.R.; Atkins, L.M. Inhibition of urease by hydroxamic acids. Arch. Int. Pharmacodyn. Ther., 1969, 180, 289-298.
8. Hase, J.; Kobashi, K. Inhibition of Proteus vulgaris urease by hydroxamic acids. J. Biochem. (Tokyo), 1967, 62, 293-299.
9. Munakata, K.; Kobashi, K.; Takebe, S.; Hase, J. Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids. J. Pharmacobiodyn., 1980, 3, 451-456.
10. Nervig, R.M.; Kaids, S. Effect of hydroxamic acids on growth and urease activity in Corynebacterium renale. Can. J. Microbiol., 1976, 22, 544-554.
11. Rosenstein, I.J.; Hamilton-Miller, J.M.; Brumfitt, W. Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect. Immun., 1981, 32, 32-37.
12. Blakeley, R.L.; Webb, E.C.; Zerner, B. Jack bean urease (EC 3.5.1.5). A new purification and reliable rat assay. Biochemistry, 1969, 8, 1984-1990.
13. Muri, E.M.F.; Mishra, H.; Stein, S.M.; Williamson, J.S. Molecular modeling, synthesis and biological evaluation of heterocyclic hydroxamic acids designed as Helicobacter pylori urease inhibitors. Lett. Drug Des. Discov., 2004, 1, 30-34.
14. Cramer, R.D.; Patterson, D.E.; Bunce, J.D. Comparative molecular field analysis (CoMFA): effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 1988, 110, 5959-5967.
15. Desiraju, G.R.; Gopalakrishnan, B.; Jetti, R.K.; Nagaraju, A.; Raveendra, D.; Sarma, J.A.; Sobhia, M.E.; Thilagavathi, R. Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives. J. Med. Chem., 2002, 45, 4847-4857.
16. Desiraju, G.R.; Sarma, J.A.; Raveendra, D.; Gopalakrishnan, B.; Thilafavathi, R.; Sobhia, M.E.; Subramanya, H.S. Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives. J. Phys. Org. Chem., 2001, 14, 481-487.
17. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem., 1994, 37, 4130-4146.
18. Zareen, A.; Atta-ur-Rahman.; Siddiquie, R.A.; Choudhary, M.I. Chemistry and mechanism of urease inhibition. Curr. Med. Chem., 2002, 9, 1323-1348.
19. Benini, S.; Rypniewski, W.R.; Wilson, K.S.; Miletti, S.; Ciurli, S.; Mangani, S. The complex of Bacillus pasteurii urease with acetohydroxamate anion from X-ray data at 1.55 Å resolution. J. Bio. Inorg. Chem., 2000, 5, 110-118.
20. SYBYL 6.9, Tripos, Inc., 1699 South Hanley Road, St. Louis, MO 63144.
21. Clark, M.; Cramer, R.D.; Van Opdenbosch, N. Validation of the general purpose of tripos 5.2 force field. J. comput. Chem., 1989, 10, 982-1012.
22. SYBYL 6.5, Tripos Associiates: Inc., 1699 South Hanley Road, St. Louis, MO, 1998.
23. Rarey, M.; Kramer, B.; Lengarer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 1996, 261, 470-489.
24. Stains, K., SYBYL Molecular Modeling software. Tripos Associate Ltd., St. Lois, MO, 1999.
25. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph., 1996, 14, 33-38.
26. Wallace, A.C.; Laskowski, R.A.; Thornton, J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng., 1995, 8, 127-134.
27. Shukla, K.L.; Gund, T.M.; Meshnick, S.R. Molecular modeling studies of the artemisinin (qinghaosu)-hemin interaction: docking between the antimalarial agent and its putative receptor. J. Mol. Graph., 1995, 13, 215-222.
28. Feng, C.; Jianhua, S.; Xiaomin, L.; Weiliang, Z.; Jiande, G.; Ruyun, J.; Hualiang, J.; Kaixian, C. Molecular docking and 3D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioor. Med. Chem., 2002, 10, 2883-2891.
29. Wold, S.; Albano, C.; Dunn, W.J.; Edlund, U.; Esbensen, K.; Geludi, P.; Hellberg, S.; Johansson, E.; Lindberg, W.; Sjöström, M. Mathematics and statistics in chemistry: Kowalski, B.R., Ed.; D. Reidel: Dordrecht, 1984, pp. 225-250.
30. Dunn, W.J.; Wold, S.; Edlund, U.; Hellberg, S. Multivariate structure-activity relationships between data from a battery of biological tests and an ensemble of structure descriptors. Qaunt. Struct.-Act. Relat., 1984, 3, 131-137.
31. Geladi, P. Notes on the history and nature of partial least squares (PLS) modeling. J. Chemometrics, 1988, 2, 231-246.
32. Wold, S. Cross-valedictory estimation of the number of components in factor and principal components models. Technometrics, 1978, 20, 397-405.
33. Jabri, E.; Carr, M.B.; Hausinger, R.P.; Karplus, P.A. The crystal structure of urease from Klebsiella aerogenes. Science, 1995, 268, 998-1004.
34. Francesco, M.; Elisa, A.; Rita, C.; Stefano, C. Structure-based computational study of the catalytic and inhibition mechanisms of urease. J. Biol. Inorg. Chem., 2001, 6, 300-314.
35. Kumaki, K.; Tomioka, S.; Kobashi, K.; Hase, J. Structure-activity correlations between hydroxamic acids and their inhibitory powers on urease activity. A quantitative approach to the effect of hydrophobic character of acyl residues. Chem. Pharm. Bull., (Tokyo) 1972, 20, 1599-1606.
36. Mishra, H.; Parrill, A.L.; Williamson, J.S. Three-dimensional quantitative structure-activity relationship and comparative molecular field analysis of dipeptide hydroxamic acid Helicobacter pylori urease inhibitors. Atimicrob. Agents Chemother., 2002, 46, 2613-2618.
37. Khan, K.M.; Iqbal, S.; Lodhi, M. A.; Maharvi, G.M.; Ullah, Z.; Choudhary, M.I.; Atta-ur-Rahman; Perveen, S. Biscoumarin: new class of urease inhibitors; economical synthesis and activity. Bioorg. Med. Chem., 2004, 12, 1963-1968.
38. Zareen, A.; Naheed, K.; Cristian, F.; Richard, F.R.; Atta-Ur-Rahman.; Syed, A. K.; Mohammad, S.S.; Jason, L.E.; Khalid, M.K.; Choudhary, M.I. Cysteine based novel noncompetitive inhibitors of urease(s) - distinctive inhibition susceptibility of microbial and plant ureases. Bioor. Med. Chem., 2006, 14, 6737-6744.